nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamivudine—ABCC3—Cyclosporine—focal segmental glomerulosclerosis	0.261	0.338	CbGbCtD
Lamivudine—ABCC1—Cyclosporine—focal segmental glomerulosclerosis	0.16	0.207	CbGbCtD
Lamivudine—ABCC2—Cyclosporine—focal segmental glomerulosclerosis	0.119	0.153	CbGbCtD
Lamivudine—ABCG2—Cyclosporine—focal segmental glomerulosclerosis	0.107	0.139	CbGbCtD
Lamivudine—SLC22A6—Cyclosporine—focal segmental glomerulosclerosis	0.0867	0.112	CbGbCtD
Lamivudine—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.0386	0.05	CbGbCtD
Lamivudine—Hyperamylasaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0266	0.191	CcSEcCtD
Lamivudine—SLC22A2—nephron—focal segmental glomerulosclerosis	0.0137	0.17	CbGeAlD
Lamivudine—PCYT2—kidney—focal segmental glomerulosclerosis	0.00983	0.122	CbGeAlD
Lamivudine—Breath sounds abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00836	0.0599	CcSEcCtD
Lamivudine—Skin infection—Cyclosporine—focal segmental glomerulosclerosis	0.00531	0.038	CcSEcCtD
Lamivudine—CMPK1—nephron tubule—focal segmental glomerulosclerosis	0.0049	0.0609	CbGeAlD
Lamivudine—NME1—kidney—focal segmental glomerulosclerosis	0.00447	0.0555	CbGeAlD
Lamivudine—CMPK1—kidney—focal segmental glomerulosclerosis	0.00431	0.0535	CbGeAlD
Lamivudine—CMPK1—cortex of kidney—focal segmental glomerulosclerosis	0.0042	0.0521	CbGeAlD
Lamivudine—SLC22A6—nephron tubule—focal segmental glomerulosclerosis	0.0032	0.0397	CbGeAlD
Lamivudine—SLC22A2—nephron tubule—focal segmental glomerulosclerosis	0.00295	0.0366	CbGeAlD
Lamivudine—Gingival bleeding—Cyclosporine—focal segmental glomerulosclerosis	0.00283	0.0202	CcSEcCtD
Lamivudine—Hypertriglyceridaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00279	0.02	CcSEcCtD
Lamivudine—SLC22A6—cortex of kidney—focal segmental glomerulosclerosis	0.00274	0.034	CbGeAlD
Lamivudine—SLC22A2—kidney—focal segmental glomerulosclerosis	0.00259	0.0322	CbGeAlD
Lamivudine—Folliculitis—Cyclosporine—focal segmental glomerulosclerosis	0.00255	0.0183	CcSEcCtD
Lamivudine—SLC22A2—cortex of kidney—focal segmental glomerulosclerosis	0.00252	0.0313	CbGeAlD
Lamivudine—Blood triglycerides increased—Cyclosporine—focal segmental glomerulosclerosis	0.00245	0.0175	CcSEcCtD
Lamivudine—DCK—nephron tubule—focal segmental glomerulosclerosis	0.00244	0.0303	CbGeAlD
Lamivudine—Myopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00229	0.0164	CcSEcCtD
Lamivudine—DCK—cortex of kidney—focal segmental glomerulosclerosis	0.00209	0.026	CbGeAlD
Lamivudine—ABCC3—kidney—focal segmental glomerulosclerosis	0.00205	0.0255	CbGeAlD
Lamivudine—Hyperaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00204	0.0146	CcSEcCtD
Lamivudine—ABCC4—nephron tubule—focal segmental glomerulosclerosis	0.00193	0.024	CbGeAlD
Lamivudine—Acne—Cyclosporine—focal segmental glomerulosclerosis	0.00191	0.0137	CcSEcCtD
Lamivudine—ABCC2—nephron tubule—focal segmental glomerulosclerosis	0.00187	0.0232	CbGeAlD
Lamivudine—SLC22A1—kidney—focal segmental glomerulosclerosis	0.00183	0.0227	CbGeAlD
Lamivudine—Rhabdomyolysis—Cyclosporine—focal segmental glomerulosclerosis	0.00181	0.013	CcSEcCtD
Lamivudine—Viral infection—Cyclosporine—focal segmental glomerulosclerosis	0.00177	0.0127	CcSEcCtD
Lamivudine—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00177	0.0127	CcSEcCtD
Lamivudine—SLC22A3—kidney—focal segmental glomerulosclerosis	0.00175	0.0217	CbGeAlD
Lamivudine—ABCC4—kidney—focal segmental glomerulosclerosis	0.0017	0.0211	CbGeAlD
Lamivudine—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00168	0.0121	CcSEcCtD
Lamivudine—ABCC4—cortex of kidney—focal segmental glomerulosclerosis	0.00165	0.0205	CbGeAlD
Lamivudine—ABCC2—kidney—focal segmental glomerulosclerosis	0.00164	0.0204	CbGeAlD
Lamivudine—ABCC2—cortex of kidney—focal segmental glomerulosclerosis	0.0016	0.0199	CbGeAlD
Lamivudine—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.00158	0.0113	CcSEcCtD
Lamivudine—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00151	0.0108	CcSEcCtD
Lamivudine—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.00145	0.0104	CcSEcCtD
Lamivudine—Gynaecomastia—Cyclosporine—focal segmental glomerulosclerosis	0.00143	0.0103	CcSEcCtD
Lamivudine—ABCC1—cortex of kidney—focal segmental glomerulosclerosis	0.00141	0.0175	CbGeAlD
Lamivudine—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.00997	CcSEcCtD
Lamivudine—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00136	0.00977	CcSEcCtD
Lamivudine—ABCG2—nephron tubule—focal segmental glomerulosclerosis	0.00136	0.0169	CbGeAlD
Lamivudine—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.00133	0.0095	CcSEcCtD
Lamivudine—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.00131	0.00941	CcSEcCtD
Lamivudine—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.0013	0.00932	CcSEcCtD
Lamivudine—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.00127	0.00907	CcSEcCtD
Lamivudine—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00122	0.00876	CcSEcCtD
Lamivudine—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00119	0.00854	CcSEcCtD
Lamivudine—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.00115	0.00821	CcSEcCtD
Lamivudine—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.00115	0.00821	CcSEcCtD
Lamivudine—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.0011	0.0079	CcSEcCtD
Lamivudine—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.00106	0.00762	CcSEcCtD
Lamivudine—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.00105	0.00751	CcSEcCtD
Lamivudine—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.00735	CcSEcCtD
Lamivudine—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.00726	CcSEcCtD
Lamivudine—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.00721	CcSEcCtD
Lamivudine—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000986	0.00707	CcSEcCtD
Lamivudine—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.00098	0.00702	CcSEcCtD
Lamivudine—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.000967	0.00693	CcSEcCtD
Lamivudine—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000964	0.00691	CcSEcCtD
Lamivudine—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.00094	0.00674	CcSEcCtD
Lamivudine—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.000929	0.00666	CcSEcCtD
Lamivudine—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000907	0.0065	CcSEcCtD
Lamivudine—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.000894	0.00641	CcSEcCtD
Lamivudine—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.000882	0.00632	CcSEcCtD
Lamivudine—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.000879	0.0063	CcSEcCtD
Lamivudine—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.000874	0.00626	CcSEcCtD
Lamivudine—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000874	0.00626	CcSEcCtD
Lamivudine—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.000848	0.00608	CcSEcCtD
Lamivudine—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.000846	0.00606	CcSEcCtD
Lamivudine—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.000841	0.00603	CcSEcCtD
Lamivudine—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.000807	0.00578	CcSEcCtD
Lamivudine—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000805	0.00577	CcSEcCtD
Lamivudine—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000801	0.00574	CcSEcCtD
Lamivudine—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.000799	0.00573	CcSEcCtD
Lamivudine—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000791	0.00567	CcSEcCtD
Lamivudine—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000726	0.0052	CcSEcCtD
Lamivudine—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.000722	0.00518	CcSEcCtD
Lamivudine—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.000711	0.0051	CcSEcCtD
Lamivudine—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.000701	0.00502	CcSEcCtD
Lamivudine—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.000691	0.00495	CcSEcCtD
Lamivudine—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.000688	0.00493	CcSEcCtD
Lamivudine—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.000686	0.00492	CcSEcCtD
Lamivudine—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.000681	0.00488	CcSEcCtD
Lamivudine—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.000674	0.00483	CcSEcCtD
Lamivudine—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.000672	0.00834	CbGeAlD
Lamivudine—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.000657	0.00471	CcSEcCtD
Lamivudine—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00065	0.00466	CcSEcCtD
Lamivudine—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000648	0.00464	CcSEcCtD
Lamivudine—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00064	0.00459	CcSEcCtD
Lamivudine—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.000632	0.00453	CcSEcCtD
Lamivudine—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00063	0.00451	CcSEcCtD
Lamivudine—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000627	0.0045	CcSEcCtD
Lamivudine—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000612	0.00438	CcSEcCtD
Lamivudine—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.000607	0.00435	CcSEcCtD
Lamivudine—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000597	0.00428	CcSEcCtD
Lamivudine—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000597	0.00428	CcSEcCtD
Lamivudine—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000597	0.00428	CcSEcCtD
Lamivudine—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000595	0.00426	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.000593	0.00425	CcSEcCtD
Lamivudine—ABCB1—kidney—focal segmental glomerulosclerosis	0.00059	0.00733	CbGeAlD
Lamivudine—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000589	0.00422	CcSEcCtD
Lamivudine—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.000584	0.00418	CcSEcCtD
Lamivudine—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000577	0.00413	CcSEcCtD
Lamivudine—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	0.000575	0.00714	CbGeAlD
Lamivudine—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000572	0.0041	CcSEcCtD
Lamivudine—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000572	0.0041	CcSEcCtD
Lamivudine—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000568	0.00407	CcSEcCtD
Lamivudine—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000561	0.00402	CcSEcCtD
Lamivudine—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00056	0.00401	CcSEcCtD
Lamivudine—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000556	0.00398	CcSEcCtD
Lamivudine—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000553	0.00396	CcSEcCtD
Lamivudine—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000545	0.00391	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000521	0.00373	CcSEcCtD
Lamivudine—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000517	0.00371	CcSEcCtD
Lamivudine—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000514	0.00368	CcSEcCtD
Lamivudine—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00051	0.00365	CcSEcCtD
Lamivudine—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000508	0.00364	CcSEcCtD
Lamivudine—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000503	0.00361	CcSEcCtD
Lamivudine—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000497	0.00356	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000494	0.00354	CcSEcCtD
Lamivudine—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000493	0.00353	CcSEcCtD
Lamivudine—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000489	0.0035	CcSEcCtD
Lamivudine—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000489	0.0035	CcSEcCtD
Lamivudine—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000471	0.00338	CcSEcCtD
Lamivudine—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000468	0.00335	CcSEcCtD
Lamivudine—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000454	0.00326	CcSEcCtD
Lamivudine—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000452	0.00324	CcSEcCtD
Lamivudine—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000452	0.00324	CcSEcCtD
Lamivudine—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000421	0.00302	CcSEcCtD
Lamivudine—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00041	0.00294	CcSEcCtD
Lamivudine—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000405	0.0029	CcSEcCtD
Lamivudine—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000391	0.0028	CcSEcCtD
Lamivudine—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000378	0.00271	CcSEcCtD
Lamivudine—PGK1—HIF-2-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	0.000364	0.0481	CbGpPWpGaD
Lamivudine—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000364	0.00261	CcSEcCtD
Lamivudine—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000361	0.00258	CcSEcCtD
Lamivudine—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00036	0.00258	CcSEcCtD
Lamivudine—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000358	0.00257	CcSEcCtD
Lamivudine—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00034	0.00243	CcSEcCtD
Lamivudine—PGK1—HIF-1-alpha transcription factor network—EDN1—focal segmental glomerulosclerosis	0.000336	0.0443	CbGpPWpGaD
Lamivudine—NME1—Arf6 trafficking events—AGTR1—focal segmental glomerulosclerosis	0.000335	0.0442	CbGpPWpGaD
Lamivudine—PGK1—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	0.000254	0.0336	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.00025	0.033	CbGpPWpGaD
Lamivudine—ABCC4—Platelet degranulation—ACTN4—focal segmental glomerulosclerosis	0.000223	0.0295	CbGpPWpGaD
Lamivudine—ABCC1—Sphingosine 1-phosphate (S1P) pathway—GNAQ—focal segmental glomerulosclerosis	0.000217	0.0287	CbGpPWpGaD
Lamivudine—PGK1—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	0.000214	0.0283	CbGpPWpGaD
Lamivudine—ABCC4—Response to elevated platelet cytosolic Ca2+—ACTN4—focal segmental glomerulosclerosis	0.000213	0.0281	CbGpPWpGaD
Lamivudine—ABCC4—Ectoderm Differentiation—PODXL—focal segmental glomerulosclerosis	0.000184	0.0243	CbGpPWpGaD
Lamivudine—ABCC3—Recycling of bile acids and salts—ALB—focal segmental glomerulosclerosis	0.00017	0.0225	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.000165	0.0218	CbGpPWpGaD
Lamivudine—NME2—Validated targets of C-MYC transcriptional activation—MMP9—focal segmental glomerulosclerosis	0.000121	0.016	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000117	0.0154	CbGpPWpGaD
Lamivudine—DCK—Retinoblastoma (RB) in Cancer—PCNA—focal segmental glomerulosclerosis	0.000107	0.0142	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000103	0.0136	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—ACTN4—focal segmental glomerulosclerosis	9.9e-05	0.0131	CbGpPWpGaD
Lamivudine—NME1—Validated targets of C-MYC transcriptional activation—MMP9—focal segmental glomerulosclerosis	9.15e-05	0.0121	CbGpPWpGaD
Lamivudine—ABCC3—Bile acid and bile salt metabolism—ALB—focal segmental glomerulosclerosis	8.9e-05	0.0118	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	8.85e-05	0.0117	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	8.33e-05	0.011	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	7.79e-05	0.0103	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	7.13e-05	0.00942	CbGpPWpGaD
Lamivudine—ABCG2—HIF-2-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	6.44e-05	0.00851	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	6.1e-05	0.00806	CbGpPWpGaD
Lamivudine—ABCG2—HIF-1-alpha transcription factor network—EDN1—focal segmental glomerulosclerosis	5.93e-05	0.00784	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	5.4e-05	0.00714	CbGpPWpGaD
Lamivudine—ABCC4—Platelet degranulation—FN1—focal segmental glomerulosclerosis	5.32e-05	0.00703	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—LIPC—focal segmental glomerulosclerosis	5.2e-05	0.00687	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—LIPC—focal segmental glomerulosclerosis	5.2e-05	0.00687	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—LIPC—focal segmental glomerulosclerosis	5.2e-05	0.00687	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—ACTN4—focal segmental glomerulosclerosis	5.1e-05	0.00674	CbGpPWpGaD
Lamivudine—ABCC4—Response to elevated platelet cytosolic Ca2+—FN1—focal segmental glomerulosclerosis	5.07e-05	0.0067	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—TRPC6—focal segmental glomerulosclerosis	4.75e-05	0.00627	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	4.68e-05	0.00618	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	4.62e-05	0.00611	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—CTGF—focal segmental glomerulosclerosis	4.58e-05	0.00605	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—CTGF—focal segmental glomerulosclerosis	4.58e-05	0.00605	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—CTGF—focal segmental glomerulosclerosis	4.58e-05	0.00605	CbGpPWpGaD
Lamivudine—ABCG2—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	4.5e-05	0.00594	CbGpPWpGaD
Lamivudine—ABCC4—Platelet degranulation—SERPINE1—focal segmental glomerulosclerosis	4.43e-05	0.00585	CbGpPWpGaD
Lamivudine—ABCC4—Platelet degranulation—ALB—focal segmental glomerulosclerosis	4.42e-05	0.00584	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—LIPC—focal segmental glomerulosclerosis	4.24e-05	0.0056	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.22e-05	0.00558	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.22e-05	0.00558	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.22e-05	0.00558	CbGpPWpGaD
Lamivudine—ABCC4—Response to elevated platelet cytosolic Ca2+—SERPINE1—focal segmental glomerulosclerosis	4.22e-05	0.00557	CbGpPWpGaD
Lamivudine—ABCC4—Response to elevated platelet cytosolic Ca2+—ALB—focal segmental glomerulosclerosis	4.21e-05	0.00556	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—GNAQ—focal segmental glomerulosclerosis	3.97e-05	0.00525	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—LIPC—focal segmental glomerulosclerosis	3.94e-05	0.00521	CbGpPWpGaD
Lamivudine—ABCG2—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	3.79e-05	0.00501	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—CTGF—focal segmental glomerulosclerosis	3.73e-05	0.00493	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	3.72e-05	0.00492	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	3.7e-05	0.0049	CbGpPWpGaD
Lamivudine—NME2—Metabolism—LIPC—focal segmental glomerulosclerosis	3.6e-05	0.00476	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	3.55e-05	0.00469	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—CTGF—focal segmental glomerulosclerosis	3.47e-05	0.00459	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.44e-05	0.00454	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	3.42e-05	0.00451	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—AGTR1—focal segmental glomerulosclerosis	3.28e-05	0.00433	CbGpPWpGaD
Lamivudine—ABCB1—HIF-1-alpha transcription factor network—EDN1—focal segmental glomerulosclerosis	3.21e-05	0.00424	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.2e-05	0.00423	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—LPL—focal segmental glomerulosclerosis	3.17e-05	0.00419	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—LPL—focal segmental glomerulosclerosis	3.17e-05	0.00419	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—LPL—focal segmental glomerulosclerosis	3.17e-05	0.00419	CbGpPWpGaD
Lamivudine—NME2—Metabolism—CTGF—focal segmental glomerulosclerosis	3.17e-05	0.00419	CbGpPWpGaD
Lamivudine—PGK1—Disease—LPL—focal segmental glomerulosclerosis	3.09e-05	0.00408	CbGpPWpGaD
Lamivudine—NME2—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.92e-05	0.00386	CbGpPWpGaD
Lamivudine—ABCC4—Platelet degranulation—TGFB1—focal segmental glomerulosclerosis	2.8e-05	0.00369	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—CD40LG—focal segmental glomerulosclerosis	2.75e-05	0.00363	CbGpPWpGaD
Lamivudine—NME1—Metabolism—LIPC—focal segmental glomerulosclerosis	2.73e-05	0.00361	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—AGT—focal segmental glomerulosclerosis	2.72e-05	0.00359	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—AGT—focal segmental glomerulosclerosis	2.72e-05	0.00359	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—AGT—focal segmental glomerulosclerosis	2.72e-05	0.00359	CbGpPWpGaD
Lamivudine—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—focal segmental glomerulosclerosis	2.66e-05	0.00352	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—LPL—focal segmental glomerulosclerosis	2.59e-05	0.00342	CbGpPWpGaD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	2.45e-05	0.00324	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—TRPC6—focal segmental glomerulosclerosis	2.45e-05	0.00323	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	2.45e-05	0.00323	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	2.44e-05	0.00323	CbGpPWpGaD
Lamivudine—ABCB1—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	2.43e-05	0.00321	CbGpPWpGaD
Lamivudine—PGK1—Disease—NOS2—focal segmental glomerulosclerosis	2.41e-05	0.00319	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—LPL—focal segmental glomerulosclerosis	2.41e-05	0.00318	CbGpPWpGaD
Lamivudine—NME1—Metabolism—CTGF—focal segmental glomerulosclerosis	2.41e-05	0.00318	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	2.36e-05	0.00312	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	2.25e-05	0.00298	CbGpPWpGaD
Lamivudine—NME1—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.22e-05	0.00293	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—AGT—focal segmental glomerulosclerosis	2.21e-05	0.00293	CbGpPWpGaD
Lamivudine—NME2—Metabolism—LPL—focal segmental glomerulosclerosis	2.2e-05	0.00291	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	2.15e-05	0.00284	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	2.12e-05	0.0028	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—ALB—focal segmental glomerulosclerosis	2.08e-05	0.00275	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—ALB—focal segmental glomerulosclerosis	2.08e-05	0.00275	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—ALB—focal segmental glomerulosclerosis	2.08e-05	0.00275	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—AGT—focal segmental glomerulosclerosis	2.06e-05	0.00272	CbGpPWpGaD
Lamivudine—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	2.05e-05	0.00271	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—GNAQ—focal segmental glomerulosclerosis	2.05e-05	0.0027	CbGpPWpGaD
Lamivudine—PGK1—Disease—SERPINE1—focal segmental glomerulosclerosis	2.03e-05	0.00269	CbGpPWpGaD
Lamivudine—SLC22A3—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	1.99e-05	0.00263	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	1.96e-05	0.0026	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—ALB—focal segmental glomerulosclerosis	1.96e-05	0.00259	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	1.91e-05	0.00253	CbGpPWpGaD
Lamivudine—NME2—Metabolism—AGT—focal segmental glomerulosclerosis	1.88e-05	0.00249	CbGpPWpGaD
Lamivudine—DCK—Metabolism—LIPC—focal segmental glomerulosclerosis	1.87e-05	0.00248	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	1.84e-05	0.00244	CbGpPWpGaD
Lamivudine—ABCC3—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	1.84e-05	0.00243	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	1.79e-05	0.00236	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	1.77e-05	0.00233	CbGpPWpGaD
Lamivudine—ABCC4—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	1.73e-05	0.00228	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—ALB—focal segmental glomerulosclerosis	1.7e-05	0.00224	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	1.68e-05	0.00223	CbGpPWpGaD
Lamivudine—NME1—Metabolism—LPL—focal segmental glomerulosclerosis	1.67e-05	0.0022	CbGpPWpGaD
Lamivudine—DCK—Metabolism—CTGF—focal segmental glomerulosclerosis	1.65e-05	0.00218	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—ALB—focal segmental glomerulosclerosis	1.58e-05	0.00209	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	1.55e-05	0.00205	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	1.54e-05	0.00203	CbGpPWpGaD
Lamivudine—DCK—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.52e-05	0.00201	CbGpPWpGaD
Lamivudine—SLC22A6—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	1.5e-05	0.00198	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	1.49e-05	0.00197	CbGpPWpGaD
Lamivudine—ABCC2—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	1.46e-05	0.00193	CbGpPWpGaD
Lamivudine—NME2—Metabolism—ALB—focal segmental glomerulosclerosis	1.44e-05	0.00191	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	1.43e-05	0.00189	CbGpPWpGaD
Lamivudine—NME1—Metabolism—AGT—focal segmental glomerulosclerosis	1.43e-05	0.00188	CbGpPWpGaD
Lamivudine—PGK1—Disease—TGFB1—focal segmental glomerulosclerosis	1.28e-05	0.0017	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.27e-05	0.00168	CbGpPWpGaD
Lamivudine—SLC22A2—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	1.25e-05	0.00165	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	1.24e-05	0.00164	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	1.24e-05	0.00163	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—FN1—focal segmental glomerulosclerosis	1.22e-05	0.00161	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—NOS2—focal segmental glomerulosclerosis	1.2e-05	0.00159	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—LIPC—focal segmental glomerulosclerosis	1.18e-05	0.00156	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	1.17e-05	0.00154	CbGpPWpGaD
Lamivudine—SLC22A1—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	1.16e-05	0.00154	CbGpPWpGaD
Lamivudine—DCK—Metabolism—LPL—focal segmental glomerulosclerosis	1.14e-05	0.00151	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	1.12e-05	0.00148	CbGpPWpGaD
Lamivudine—NME1—Metabolism—ALB—focal segmental glomerulosclerosis	1.09e-05	0.00145	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—LIPC—focal segmental glomerulosclerosis	1.09e-05	0.00144	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—CTGF—focal segmental glomerulosclerosis	1.04e-05	0.00138	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	1.01e-05	0.00134	CbGpPWpGaD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.01e-05	0.00134	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—ALB—focal segmental glomerulosclerosis	1.01e-05	0.00134	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	9.99e-06	0.00132	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	9.78e-06	0.00129	CbGpPWpGaD
Lamivudine—DCK—Metabolism—AGT—focal segmental glomerulosclerosis	9.78e-06	0.00129	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—GNAQ—focal segmental glomerulosclerosis	9.6e-06	0.00127	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CTGF—focal segmental glomerulosclerosis	9.58e-06	0.00127	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	9.3e-06	0.00123	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—GNAQ—focal segmental glomerulosclerosis	8.82e-06	0.00117	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	8.75e-06	0.00116	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—LIPC—focal segmental glomerulosclerosis	8.52e-06	0.00113	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	8.4e-06	0.00111	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	7.67e-06	0.00101	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	7.61e-06	0.00101	CbGpPWpGaD
Lamivudine—DCK—Metabolism—ALB—focal segmental glomerulosclerosis	7.51e-06	0.000992	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CTGF—focal segmental glomerulosclerosis	7.5e-06	0.000992	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—LIPC—focal segmental glomerulosclerosis	7.5e-06	0.000991	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—LIPC—focal segmental glomerulosclerosis	7.42e-06	0.000981	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	7.38e-06	0.000975	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	7.29e-06	0.000963	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—LPL—focal segmental glomerulosclerosis	7.22e-06	0.000954	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—LIPC—focal segmental glomerulosclerosis	6.92e-06	0.000914	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GNAQ—focal segmental glomerulosclerosis	6.91e-06	0.000914	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—LPL—focal segmental glomerulosclerosis	6.64e-06	0.000877	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CTGF—focal segmental glomerulosclerosis	6.6e-06	0.000873	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CTGF—focal segmental glomerulosclerosis	6.53e-06	0.000864	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	6.41e-06	0.000848	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—TGFB1—focal segmental glomerulosclerosis	6.39e-06	0.000845	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	6.35e-06	0.000839	CbGpPWpGaD
Lamivudine—ABCC1—Disease—LPL—focal segmental glomerulosclerosis	6.21e-06	0.000821	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—AGT—focal segmental glomerulosclerosis	6.18e-06	0.000816	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CTGF—focal segmental glomerulosclerosis	6.09e-06	0.000805	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GNAQ—focal segmental glomerulosclerosis	6.08e-06	0.000804	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GNAQ—focal segmental glomerulosclerosis	6.02e-06	0.000796	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	5.92e-06	0.000782	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—AGT—focal segmental glomerulosclerosis	5.68e-06	0.00075	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GNAQ—focal segmental glomerulosclerosis	5.61e-06	0.000742	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	5.52e-06	0.00073	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—LPL—focal segmental glomerulosclerosis	5.2e-06	0.000687	CbGpPWpGaD
Lamivudine—ABCC1—Disease—NOS2—focal segmental glomerulosclerosis	4.85e-06	0.000641	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—ALB—focal segmental glomerulosclerosis	4.74e-06	0.000626	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—LPL—focal segmental glomerulosclerosis	4.58e-06	0.000605	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—LPL—focal segmental glomerulosclerosis	4.53e-06	0.000599	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—AGT—focal segmental glomerulosclerosis	4.45e-06	0.000588	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—ALB—focal segmental glomerulosclerosis	4.36e-06	0.000576	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—LPL—focal segmental glomerulosclerosis	4.22e-06	0.000558	CbGpPWpGaD
Lamivudine—ABCC1—Disease—SERPINE1—focal segmental glomerulosclerosis	4.08e-06	0.00054	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	4.05e-06	0.000536	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—AGT—focal segmental glomerulosclerosis	3.91e-06	0.000517	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—AGT—focal segmental glomerulosclerosis	3.87e-06	0.000512	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—AGT—focal segmental glomerulosclerosis	3.61e-06	0.000477	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	3.57e-06	0.000472	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	3.47e-06	0.000458	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ALB—focal segmental glomerulosclerosis	3.41e-06	0.000451	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.29e-06	0.000435	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ALB—focal segmental glomerulosclerosis	3e-06	0.000397	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ALB—focal segmental glomerulosclerosis	2.97e-06	0.000393	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ALB—focal segmental glomerulosclerosis	2.77e-06	0.000366	CbGpPWpGaD
Lamivudine—ABCC1—Disease—TGFB1—focal segmental glomerulosclerosis	2.58e-06	0.000341	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	2.47e-06	0.000327	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	2.12e-06	0.00028	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	1.62e-06	0.000215	CbGpPWpGaD
